» Articles » PMID: 39174968

Using the Behaviour Change Wheel to Develop a Tailored Intervention to Overcome General Practitioners' Perceived Barriers to Referring Insomnia Patients to Digital Therapeutic Sleepio

Overview
Publisher Biomed Central
Specialty Health Services
Date 2024 Aug 22
PMID 39174968
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Digital therapeutic Sleepio has proven effective in improving sleep quality and decreasing symptoms of anxiety. The National Institute for Health and Care Excellence (NICE) guidance recommends Sleepio as an alternative treatment to usual sleep hygiene education and hypnotic medications. General practitioners (GPs) play a critical role in the adoption of digital therapeutics in patient care. Previous interventions did not adopt theoretical frameworks to systematically understand GPs behaviour toward referring patients to digital therapeutics.

Objectives: This study aimed to report the systematic and comprehensive development of an intervention to encourage GPs to refer insomnia patients to Sleepio, using the Behaviour Change Wheel (BCW).

Methods: The eight steps outlined in the BCW were followed to develop an intervention. The Capability Opportunity Motivation-Behaviour Self-Evaluation Questionnaire (COM-B-Qv1) was adopted to understand GPs perceived facilitators and barriers to refer insomnia patients to Sleepio. The Behaviour Change Technique Taxonomy Version 1 (BCTv1) was thereafter used to identify possible strategies that could be used to facilitate changes in GPs' behaviour in relation to Sleepio.

Results: The BCW design process resulted in the identification of five intervention functions, three policy categories and five behaviour change techniques (BCTs) as potential active components for an intervention. The intervention includes providing GPs with an orientation about using Sleepio to improve their knowledge and confidence, sending visual reminders to GPs to recommend Sleepio to their patients, providing ongoing technical support.

Conclusion: The BCW can be successfully applied through a systematic process to understand the drivers of GPs' behaviour and to develop an intervention that can encourage them to refer insomnia patients to Sleepio.

References
1.
Panneman M, Goettsch W, Kramarz P, Herings R . The costs of benzodiazepine-associated hospital-treated fall Injuries in the EU: a Pharmo study. Drugs Aging. 2003; 20(11):833-9. DOI: 10.2165/00002512-200320110-00004. View

2.
Henry A, Miller C, Emsley R, Sheaves B, Freeman D, Luik A . Does treating insomnia with digital cognitive behavioural therapy (Sleepio) mediate improvements in anxiety for those with insomnia and comorbid anxiety? An analysis using individual participant data from two large randomised controlled trials. J Affect Disord. 2023; 339:58-63. DOI: 10.1016/j.jad.2023.06.053. View

3.
Madari S, Golebiowski R, Mansukhani M, Kolla B . Pharmacological Management of Insomnia. Neurotherapeutics. 2021; 18(1):44-52. PMC: 8116439. DOI: 10.1007/s13311-021-01010-z. View

4.
Reid H, Smith R, Williamson W, Baldock J, Caterson J, Kluzek S . Use of the behaviour change wheel to improve everyday person-centred conversations on physical activity across healthcare. BMC Public Health. 2022; 22(1):1784. PMC: 9487060. DOI: 10.1186/s12889-022-14178-6. View

5.
Saddichha S . Diagnosis and treatment of chronic insomnia. Ann Indian Acad Neurol. 2010; 13(2):94-102. PMC: 2924526. DOI: 10.4103/0972-2327.64628. View